Applicants must have
a medical degree (including MD, DO, or MD/PhD) in a related field, and not
currently be a candidate for a further doctoral degree. Additionally, at the start of the grant term, eligible applicants must have completed their most recent residency within the past five years and must be currently working at an academic, medical, or research institution within the United States.
Clinical researchers currently enrolled in an accredited hematology/oncology or radiation oncology fellowship program at an academic, medical, or research institution within the United States are particularly encouraged to apply. Exceptional senior residents are also encouraged to apply.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.
Clinical Fellows applying from a U.S. government
laboratory (e.g., NIH, CDC, FDA, etc.) are not eligible.
Any individual who currently holds an active AACR grant may not apply. Past grantees may apply if they complied with all progress and financial report requirements.
Investigators may submit only one application for the AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowships but may concurrently apply for other AACR grants. However, applicants are expected to accept the first grant they are awarded. Individuals may accept and hold only one AACR grant at a time.
All applicants with questions about eligibility must contact AACR’s Scientific Review and Grants Administration department (AACR’s SRGA) before submitting an application.